Literature DB >> 19395354

Beyond the numbers: expanding the boundaries of neuropsychology.

William Perry1.   

Abstract

Beyond the Numbers: Expanding the Boundaries of Neuropsychology was Dr Perry's 2007 presidential address in the annual conference of the National Academy of Neuropsychology. In his address he discussed the achievements of the science of neuropsychology and highlighted some areas that exemplified the expansion of the boundaries of neuropsychology. These areas are: (i) the study of neuropsychological functioning in new or non-traditional populations, particularly seemingly healthy people and people with non-brain diseases; (ii) the interface of cognition and genetics; (iii) the use of the process approach as a means of understanding brain functioning; and (iv) a translational application to the science of neuropsychology.

Entities:  

Mesh:

Year:  2009        PMID: 19395354      PMCID: PMC2764504          DOI: 10.1093/arclin/acp001

Source DB:  PubMed          Journal:  Arch Clin Neuropsychol        ISSN: 0887-6177            Impact factor:   2.813


  23 in total

1.  A retrospective review of the neuropsychological test performance of physicians referred for medical infractions.

Authors:  William Perry; Rebecca D Crean
Journal:  Arch Clin Neuropsychol       Date:  2005-03       Impact factor: 2.813

Review 2.  The neuropsychology of recurrent headache.

Authors:  Sid E O'Bryant; Dawn A Marcus; Jeanetta C Rains; Donald B Penzien
Journal:  Headache       Date:  2006-10       Impact factor: 5.887

3.  Cognition, MRS neurometabolites, and MRI volumetrics in non-neuropsychiatric systemic lupus erythematosus: preliminary data.

Authors:  Elizabeth Kozora; David B Arciniegas; Christopher M Filley; Misoo C Ellison; Sterling G West; Mark S Brown; Jack H Simon
Journal:  Cogn Behav Neurol       Date:  2005-09       Impact factor: 1.600

4.  Elevated body mass index is associated with executive dysfunction in otherwise healthy adults.

Authors:  John Gunstad; Robert H Paul; Ronald A Cohen; David F Tate; Mary Beth Spitznagel; Evian Gordon
Journal:  Compr Psychiatry       Date:  2006-06-30       Impact factor: 3.735

5.  Self-monitoring enhances Wisconsin Card Sorting Test performance in patients with schizophrenia: performance is improved by simply asking patients to verbalize their sorting strategy.

Authors:  W Perry; E G Potterat; D L Braff
Journal:  J Int Neuropsychol Soc       Date:  2001-03       Impact factor: 2.892

6.  Older adults with cognitive complaints show brain atrophy similar to that of amnestic MCI.

Authors:  A J Saykin; H A Wishart; L A Rabin; R B Santulli; L A Flashman; J D West; T L McHugh; A C Mamourian
Journal:  Neurology       Date:  2006-09-12       Impact factor: 9.910

7.  Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia.

Authors:  M F Egan; T E Goldberg; B S Kolachana; J H Callicott; C M Mazzanti; R E Straub; D Goldman; D R Weinberger
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-29       Impact factor: 11.205

8.  Adults with autism show increased sensitivity to outcomes at low error rates during decision-making.

Authors:  Arpi Minassian; Martin Paulus; Alan Lincoln; William Perry
Journal:  J Autism Dev Disord       Date:  2006-11-01

Review 9.  Cognitive and psychological issues in emphysema.

Authors:  Elizabeth Kozora; Charles Emery; Robert M Kaplan; Fredrick S Wamboldt; Lening Zhang; Barry J Make
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

10.  Pathogenesis of hepatitis C virus coinfection in the brains of patients infected with HIV.

Authors:  Scott Letendre; Amy D Paulino; Edward Rockenstein; Anthony Adame; Leslie Crews; Mariana Cherner; Robert Heaton; Ronald Ellis; Ian P Everall; Igor Grant; Eliezer Masliah
Journal:  J Infect Dis       Date:  2007-06-15       Impact factor: 5.226

View more
  1 in total

Review 1.  Epigenetics and biomarkers in the staging of neuropsychiatric disorders.

Authors:  Trevor Archer; Richard J Beninger; Tomas Palomo; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2010-03-17       Impact factor: 3.911

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.